Alterations in antral cytokine gene expression in peptic ulcer patients during ulcer healing and after Helicobacter pylori eradication

Scandinavian Journal of Immunology

Volumn 67, Issue 1, 2008, Pages 57-62

  Goll, R ^a,b   Cui, G ^a   Olsen, T ^a   Isaksen, V ^c   Gruber, F ^d   Husebekk, A ^a,c   Florholmen, J ^a,b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b Department of Medical Gastroenterology ^*  (Norway)

^c UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^d Institute of Pharmacy   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; PROTON PUMP INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; ERADICATION THERAPY; FEMALE; FOLLOW UP; GASTRITIS; GASTROINTESTINAL ENDOSCOPY; GENE CONTROL; GENE EXPRESSION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; INFLAMMATION; MALE; MONONUCLEAR CELL; NEUTROPHIL; PEPTIC ULCER; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STOMACH ANTRUM; STOMACH BIOPSY; TH1 CELL; ULCER HEALING;

ADULT; AGED; AGED, 80 AND OVER; CYTOKINES; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, BACTERIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PEPTIC ULCER; PYLORIC ANTRUM;

EID: 36749082974     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2007.02037.x     Document Type: Article

References (32)

1. Berstad A, Olafsson S, Tefera S, Hatlebakk JG, Gilja OH, Hausken T Controversies in dyspepsia. Eur J Surg Suppl 2001 586:4 11.
2. Blaser MJ. Ecology of Helicobacter pylori in the human stomach. J Clin Invest 1997 100:759 62.
3. Ernst P. Review article: the role of inflammation in the pathogenesis of gastric cancer. Aliment Pharmacol Ther 1999 13 (Suppl. 1 13 8.
4. Ford AC, Delaney BC, Forman D, Moayyedi P. Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients. Cochrane Database Syst Rev 2006 2:CD003840. doi:.
5. Chang YT, Wu MS, Shun CT, Lin MT, Chang MC, Lin JT. Association of polymorphisms of interleukin-1 beta gene and Helicobacter pylori infection with the risk of gastric ulcer. Hepatogastroenterology 2002 49:1474 6.
6. Gyulai Z, Klausz G, Tiszai A et al. Genetic polymorphism of interleukin-8 (IL-8) is associated with Helicobacter pylori-induced duodenal ulcer. Eur Cytokine Netw 2004 15:353 8.
7. Togawa S, Joh T, Itoh M et al. Interleukin-2 gene polymorphisms associated with increased risk of gastric atrophy from Helicobacter pylori infection. Helicobacter 2005 10:172 8.
8. Furuta T, El Omar EM, Xiao F, Shirai N, Takashima M, Sugimura H. Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 2002 123:92 105.
9. McGee DJ, Mobley HL. Mechanisms of Helicobacter pylori infection: bacterial factors. Curr Top Microbiol Immunol 1999 241:155 80.
10. Zambon CF, Basso D, Navaglia F et al. Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine 2005 29:141 52.
11. Franceschi F, Genta RM, Sepulveda AR. Gastric mucosa: long-term outcome after cure of Helicobacter pylori infection. J.Gastroenterol 2002 37 (Suppl. 13 17 23.
12. Ito M, Haruma K, Kamada T et al. Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis. Aliment Pharmacol Ther 2002 16:1449 56.
13. Goll R, Gruber FX, Olsen T et al. Helicobacter pylori stimulates a mixed adaptive immune response with a strong T-regulatory component in human gastric mucosa. Helicobacter 2007 12:185 92.
14. Ihan A, Tepez B, Gubina M, Malovrh T, Kopitar A. Diminished interferon-gamma production in gastric mucosa T lymphocytes after H. pylori eradication in duodenal ulcer patients. Hepatogastroenterology 1999 46:1740 5.
15. Dore MP, Fastame L, Tocco A, Negrini R, Delitala G, Realdi G. Immunity markers in patients with Helicobacter pylori infection: effect of eradication. Helicobacter 2005 10:391 7.
16. Ihan A, Tepes B, Gubina M. Diminished Th1-type cytokine production in gastric mucosa T-lymphocytes after H. pylori eradication in duodenal ulcer patients. Pflugers Arch 2000 440:R89 90.
17. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996 20:1161 81.
18. Cui G, Olsen T, Christiansen I, Vonen B, Florholmen J, Goll R. Improvement of real-time polymerase chain reaction for quantifying TNF-alpha mRNA expression in inflamed colorectal mucosa: An approach to optimize procedures for clinical use. Scand J Clin Lab Invest 2006 66:249 59.
19. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001 25:402 8.
20. Goll R, Husebekk A, Isaksen V, Kauric G, Hansen T, Florholmen J. Increased frequency of antral CD4 T and CD19 B cells in patients with Helicobacter pylori-related peptic ulcer disease. Scand J Immunol 2005 61:92 7.
21. Lindholm C, Quiding-Jarbrink M, Lonroth H, Hamlet A, Svennerholm AM. Local cytokine response in Helicobacter pylori-infected subjects. Infect Immun 1998 66:5964 71.
22. Yamaoka Y, Kodama T, Kita M, Imanishi J, Kashima K, Graham DY. Relation between clinical presentation, Helicobacter pylori density, interleukin 1beta and 8 production, and cagA status. Gut 1999 45:804 11.
23. Hida N, Shimoyama T Jr., Neville P et al. Increased expression of IL-10 and IL-12 (p40) mRNA in Helicobacter pylori infected gastric mucosa: relation to bacterial cag status and peptic ulceration. J Clin Pathol 1999 52:658 64.
24. Itoh T, Seno H, Kita T, Chiba T, Wakatsuki Y. The response to Helicobacter pylori differs between patients with gastric ulcer and duodenal ulcer. Scand J Gastroenterol 2005 40:641 7.
25. Messa C, Di Leo A, Greco B et al. Successful eradicating treatment of Helicobacter pylori in patients with chronic gastritis: gastric levels of cytokines, epidermal growth factor and polyamines before and after therapy. Immunopharmacol Immunotoxicol 1996 18:1 13.
26. Park SM, Kim JH, Hong YH et al. Expression of mucosal cyto-chemokine mRNAs in patients with Helicobacter pylori infection. Korean J Intern Med 2001 16:230 5.
27. Russo F, Messa C, Amati L et al. The influence of Helicobacter pylori eradication on the gastric mucosal content of epidermal growth factor, transforming growth factor-alpha, and their common receptor. Scand J Gastroenterol 1998 33:271 5.
28. Wang M, Furuta T, Takashima M et al. Relation between interleukin-1beta messenger RNA in gastric fundic mucosa and gastric juice pH in patients infected with Helicobacter pylori. J Gastroenterol 1999 34 (Suppl. 11 10 7.
29. Ando T, Kusugami K, Ohsuga M et al. Differential normalization of mucosal interleukin-8 and interleukin-6 activity after Helicobacter pylori eradication. Infect Immun 1998 66:4742 7.
30. Moss SF, Legon S, Davies J, Calam J. Cytokine gene expression in Helicobacter pylori associated antral gastritis. Gut 1994 35:1567 70.
31. Kikuchi T, Kato K, Ohara S et al. The relationship between persistent secretion of RANTES and residual infiltration of eosinophils and memory T lymphocytes after Helicobacter pylori eradication. J Pathol 2000 192:243 50.
32. Mills KH. Regulatory T cells: friend or foe in immunity to infection? Nat Rev Immunol 2004 4:841 55.